Skip Header

 
Contribute Send feedback

Reviewed, UniProtKB/Swiss-Prot O43707 (ACTN4_HUMAN)

Last modified September 2, 2008. Version 104. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (7) | Third-party data | Customize display text xml rdf/xml gff fasta
Names and origin · Protein attributes · General annotation (Comments) · Ontologies · Binary interactions · Sequence annotation (Features) · Sequences · References · Web resources · Cross-references · Entry information · Relevant documents

Names and origin

Protein namesRecommended name:
    Alpha-actinin-4
Alternative name(s):
    Non-muscle alpha-actinin 4
    F-actin cross-linking protein
Gene names
Name: ACTN4
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length911 AA.
Sequence statusComplete.
Sequence processingThe displayed sequence is not processed.
Protein existenceEvidence at protein level.

General annotation (Comments)

Function

F-actin cross-linking protein which is thought to anchor actin to a variety of intracellular structures. This is a bundling protein.

Subunit structure

Homodimer; antiparallel By similarity. Binds TRIM3 at the N-terminus By similarity. Interacts with BAIAP1 and PDLIM2.

Subcellular location

Nucleus. Cytoplasm. Note= Colocalizes with actin stress fibers. Nuclear translocation can be induced by the PI3 kinase inhibitor wortmannin or by cytochalasin D. Exclusively localized in the nucleus in a limited number of cell lines (breast cancer cell line MCF7, oral floor cancer IMC2, and bladder cancer KU7).

Tissue specificity

Widely expressed.

Involvement in disease

Cytoplasmic localization of ACTN4 may be associated with cancer metastases due to enhanced cell motility.

Defects in ACTN4 are the cause of focal segmental glomerulosclerosis 1 (FSGS1) [MIM:603278]. FSGS1 is a common renal lesion characterized by increased urinary protein excretion (proteinuria) and decreasing kidney function (nephrotic syndrome). Renal insufficiency often progresses to end-stage renal disease (ESRD) (also known as end-stage renal failure), a highly morbid state requiring either dialysis therapy or kidney transplantation. FSGS1 is defined by the presence of segmental sclerosis in glomeruli, and is seen in all ethnic groups, although it is particularly common in individuals of African descent. FSGS1 occurs as an isolated primary condition or secondary to disorders as HIV infection, obesity, hypertension and diabetes. FSGS1 may also be inherited as a Mendelian trait.

Sequence similarities

Belongs to the alpha-actinin family.

Contains 1 actin-binding domain.

Contains 2 CH (calponin-homology) domains.

Contains 2 EF-hand domains.

Contains 4 spectrin repeats.

Sequence caution

The sequence AAC17470.1 differs from that shown. Reason: Frameshift at several positions.

The sequence AAC17470.1 differs from that shown. Reason: Miscellaneous discrepancy. Sequencing errors. Compared to other mammalian sequences.

Binary interactions

With

Entry

#Exp.

IntAct

Notes

CTNNB1P352221EBI-351526,EBI-491549
TJP1Q071572EBI-351526,EBI-79553

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical view

Molecule processing

Chain1 – 911911Alpha-actinin-4

Regions

Domain1 – 269269Actin-binding
Domain50 – 154105CH 1
Domain163 – 269107CH 2
Repeat293 – 403111Spectrin 1
Repeat413 – 518106Spectrin 2
Repeat528 – 639112Spectrin 3
Repeat649 – 752104Spectrin 4
Domain765 – 80036EF-hand 1
Domain806 – 84136EF-hand 2
Calcium binding778 – 789121 Potential
Calcium binding819 – 830122 Potential
Region177 – 19216Polyphosphoinositide (PIP2)-binding Potential
Compositional bias19 – 268Poly-Gly

Amino acid modifications

Modified residue2651Phosphotyrosine
Cross-link378Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin)

Natural variations

Natural variant2551K → E in FSGS1.
Natural variant2591T → I in FSGS1.
Natural variant2621S → P in FSGS1.

Experimental info

Sequence conflict601C → S in AAC17470. Ref.3
Sequence conflict1241V → I Ref.3
Sequence conflict1641S → L in AL047603 and AU118403. Ref.4
Sequence conflict2761T → TET Ref.3
Sequence conflict292 – 2943EHL → CSTS in AAC17470. Ref.3
Sequence conflict359 – 3602TL → SV in AAC17470. Ref.3
Sequence conflict4761I → S in AAC17470. Ref.3
Sequence conflict5261I → II in AAC17470. Ref.3
Sequence conflict5361R → P in AAC17470. Ref.3
Sequence conflict6451Q → QQ in AAC17470. Ref.3
Sequence conflict673 – 6742GR → A in AAC17470. Ref.3
Sequence conflict8501A → T in AAC17470. Ref.3
Sequence conflict8591Missing Ref.3
Sequence conflict891 – 8933AVP → GVR in AAC17470. Ref.3

Secondary structure

.................................. 911
Helix Strand Turn

Details...

Sequences

Sequence LengthMass (Da)Tools
O43707-1 [UniParc].

Last modified February 21, 2001. Version 2.
Checksum: 461580C3F22937D1

FASTA911104,854
        10         20         30         40         50         60 
MVDYHAANQS YQYGPSSAGN GAGGGGSMGD YMAQEDDWDR DLLLDPAWEK QQRKTFTAWC 

        70         80         90        100        110        120 
NSHLRKAGTQ IENIDEDFRD GLKLMLLLEV ISGERLPKPE RGKMRVHKIN NVNKALDFIA 

       130        140        150        160        170        180 
SKGVKLVSIG AEEIVDGNAK MTLGMIWTII LRFAIQDISV EETSAKEGLL LWCQRKTAPY 

       190        200        210        220        230        240 
KNVNVQNFHI SWKDGLAFNA LIHRHRPELI EYDKLRKDDP VTNLNNAFEV AEKYLDIPKM 

       250        260        270        280        290        300 
LDAEDIVNTA RPDEKAIMTY VSSFYHAFSG AQKAETAANR ICKVLAVNQE NEHLMEDYEK 

       310        320        330        340        350        360 
LASDLLEWIR RTIPWLEDRV PQKTIQEMQQ KLEDFRDYRR VHKPPKVQEK CQLEINFNTL 

       370        380        390        400        410        420 
QTKLRLSNRP AFMPSEGKMV SDINNGWQHL EQAEKGYEEW LLNEIRRLER LDHLAEKFRQ 

       430        440        450        460        470        480 
KASIHEAWTD GKEAMLKHRD YETATLSDIK ALIRKHEAFE SDLAAHQDRV EQIAAIAQEL 

       490        500        510        520        530        540 
NELDYYDSHN VNTRCQKICD QWDALGSLTH SRREALEKTE KQLEAIDQLH LEYAKRAAPF 

       550        560        570        580        590        600 
NNWMESAMED LQDMFIVHTI EEIEGLISAH DQFKSTLPDA DREREAILAI HKEAQRIAES 

       610        620        630        640        650        660 
NHIKLSGSNP YTTVTPQIIN SKWEKVQQLV PKRDHALLEE QSKQQSNEHL RRQFASQANV 

       670        680        690        700        710        720 
VGPWIQTKME EIGRISIEMN GTLEDQLSHL KQYERSIVDY KPNLDLLEQQ HQLIQEALIF 

       730        740        750        760        770        780 
DNKHTNYTME HIRVGWEQLL TTIARTINEV ENQILTRDAK GISQEQMQEF RASFNHFDKD 

       790        800        810        820        830        840 
HGGALGPEEF KACLISLGYD VENDRQGEAE FNRIMSLVDP NHSGLVTFQA FIDFMSRETT 

       850        860        870        880        890        900 
DTDTADQVIA SFKVLAGDKN FITAEELRRE LPPDQAEYCI ARMAPYQGPD AVPGALDYKS 

       910 
FSTALYGESD L 

« Hide

References

« Hide 'large scale' references
[1]"Actinin-4, a novel actin-bundling protein associated with cell motility and cancer invasion."
Honda K., Yamada T., Endo R., Ino Y., Gotoh M., Tsuda H., Yamada Y., Chiba H., Hirohashi S.
J. Cell Biol. 140:1383-1393(1998) [PubMed: 9508771] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 4-911.
[2]Erratum
Honda K., Yamada T., Endo R., Ino Y., Gotoh M., Tsuda H., Yamada Y., Chiba H., Hirohashi S.
J. Cell Biol. 143:276-276(1998)
[3]"The human non-muscle alpha-actinin protein encoded by the ACTN4 gene suppresses tumorigenicity of human neuroblastoma cells."
Nikolopoulos S.N., Spengler B.A., Kisselbach K., Evans A.E., Biedler J.L., Ross R.A.
Oncogene 19:380-386(2000) [PubMed: 10656685] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA].
Tissue: Neuroblastoma.
[4]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
Tissue: Placenta.
[5]The German cDNA consortium
Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-170.
Tissue: Uterus.
[6]Isogai T., Otsuki T., Sugiyama T.
Submitted (OCT-2000) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-218.
[7]"Interaction of two actin-binding proteins, synaptopodin and alpha-actinin-4, with the tight junction protein MAGI-1."
Patrie K.M., Drescher A.J., Welihinda A., Mundel P., Margolis B.
J. Biol. Chem. 277:30183-30190(2002) [PubMed: 12042308] [Abstract]
Cited for: INTERACTION WITH BAIAP1.
[8]"Immunoaffinity profiling of tyrosine phosphorylation in cancer cells."
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H., Zha X.-M., Polakiewicz R.D., Comb M.J.
Nat. Biotechnol. 23:94-101(2005) [PubMed: 15592455] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-265, MASS SPECTROMETRY.
[9]"Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer."
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J., Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L., Mitchell J., Wetzel R., Macneill J., Ren J.M. expand/collapse author list , Yuan J., Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X., Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.
Cell 131:1190-1203(2007) [PubMed: 18083107] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-265, MASS SPECTROMETRY.
[10]"Tryptic digestion of ubiquitin standards reveals an improved strategy for identifying ubiquitinated proteins by mass spectrometry."
Denis N.J., Vasilescu J., Lambert J.-P., Smith J.C., Figeys D.
Proteomics 7:868-874(2007) [PubMed: 17370265] [Abstract]
Cited for: UBIQUITINATION [LARGE SCALE ANALYSIS] AT LYS-378, MASS SPECTROMETRY.
[11]"Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis."
Kaplan J.M., Kim S.H., North K.N., Rennke H., Correia L.A., Tong H.-Q., Mathis B.J., Rodriguez-Perez J.-C., Allen P.G., Beggs A.H., Pollak M.R.
Nat. Genet. 24:251-256(2000) [PubMed: 10700177] [Abstract]
Cited for: VARIANTS FSGS1 GLU-255; ILE-259 AND PRO-262.
Tissue: Lymphocyte.
+Additional computationally mapped references.

Web resources

Cross-references

Sequence databases

D89980 mRNA. Translation: BAA24447.1. Different initiation.
U48734 mRNA. Translation: AAC17470.1. Sequence problems.
BC005033 mRNA. Translation: AAH05033.1.
AL047603 mRNA. No translation available.
AU118403 mRNA. No translation available.
RefSeqNP_004915.2.
UniGeneHs.270291

3D structure databases

EntryMethodResolution (Å)ChainPositionsPDBsum
1WLXNMR-A519-645[»]
1YDIX-ray1.80B734-757[»]
2R0OX-ray2.20A/B44-271[»]
SMRO43707. Positions 44-911.
ModBaseSearch...

Protein-protein interaction databases

IntActO43707.

PTM databases

PhosphoSiteO43707.

2-D gel databases

REPRODUCTION-2DPAGEO43707.

Proteomic databases

PeptideAtlasO43707.

Genome annotation databases

EnsemblENSG00000130402. Homo sapiens. [Contig view]
GeneID81.
KEGGhsa:81.

Organism-specific databases

H-InvDBHIX0015097.
HGNCHGNC:166. ACTN4.